Aradhye Shreeram 4
4 · Axcella Health Inc. · Filed Dec 20, 2019
Insider Transaction Report
Form 4
Aradhye Shreeram
EVP & Chief Developmnt Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-12-18+54,500→ 54,500 totalExercise: $3.40Exp: 2029-12-18→ Common Stock (54,500 underlying) - Award
Restricted Stock Units
2019-12-18+66,801→ 66,801 total→ Common Stock (66,801 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on December 18, 2020, with the remainder to vest in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
- [F3]The restricted stock units vest as follows: 1/3 of the grant shall vest on December 18, 2021; and the remaining 2/3 of the grant shall vest on December 18, 2022.